Eye drops for eye alignment and double-vision control in children
Treatments studied
Part of Brain & nervous system, Eyes & vision clinical trials.
This study tests eye drops to improve how a child’s eyes line up and how well they can use both eyes together. It may help children with certain types of outward eye drifting (intermittent exotropia/exophoria).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (and your child) must be between ages 5 and 14
- The child’s glasses prescription must fit specific astigmatism and near-match between eyes
- Eye pressure must be under 21 mmHg
- The child must have the specific type of outward drifting of the eyes (near and/or distance), based on exam results
- The child must not have amblyopia (lazy eye) or have had other eye surgeries before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.
This trial tests whether atropine eye drops can reduce the progression of myopia (nearsightedness, where you have trouble seeing far away) in children. It might help slow down the worsening of vision over time.
This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).
This study compares two ways to slow down worsening nearsightedness in children: special electronic glasses versus low-dose atropine eye drops. It may help your child keep their eyesight from getting much worse over time.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
Hear when a new Exotropia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.